抗vzv(抗hsv3)疫苗对HSV1和HSV2复发性单纯疱疹的疗效:一项前瞻性研究

IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

Open Access Journal of Clinical Trials Pub Date : 2012-07-30 DOI:10.2147/OAJCT.S33292

J. L. Goaster, Gonzalo, Bourée, Frderic Tangy, Haenni

{"title":"抗vzv(抗hsv3)疫苗对HSV1和HSV2复发性单纯疱疹的疗效:一项前瞻性研究","authors":"J. L. Goaster, Gonzalo, Bourée, Frderic Tangy, Haenni","doi":"10.2147/OAJCT.S33292","DOIUrl":null,"url":null,"abstract":"Jacqueline Le Goaster1 Sylvie Gonzalo2 Patrice Bouree1 Frederic Tangy3 Anne-Lise Haenni4 1Department of Tropical Diseases, Centre Hospitalo-Universitaire (CHU), University of Paris XI, Le Kremlin Bicetre, 2Biomnis Laboratory, Ivry-sur-Seine, 3Retro-Virology, Centre National de Recherche Scientifique (CNRS), Pasteur Institute, Paris; 4Jacques Monod Institute, Centre National de Recherche Scientifique (CNRS), University of Paris VII, Paris, France","PeriodicalId":19500,"journal":{"name":"Open Access Journal of Clinical Trials","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2012-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/OAJCT.S33292","citationCount":"8","resultStr":"{\"title\":\"Efficacy of the anti-VZV (anti-HSV3) vaccine in HSV1 and HSV2 recurrent herpes simplex disease: a prospective study\",\"authors\":\"J. L. Goaster, Gonzalo, Bourée, Frderic Tangy, Haenni\",\"doi\":\"10.2147/OAJCT.S33292\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Jacqueline Le Goaster1 Sylvie Gonzalo2 Patrice Bouree1 Frederic Tangy3 Anne-Lise Haenni4 1Department of Tropical Diseases, Centre Hospitalo-Universitaire (CHU), University of Paris XI, Le Kremlin Bicetre, 2Biomnis Laboratory, Ivry-sur-Seine, 3Retro-Virology, Centre National de Recherche Scientifique (CNRS), Pasteur Institute, Paris; 4Jacques Monod Institute, Centre National de Recherche Scientifique (CNRS), University of Paris VII, Paris, France\",\"PeriodicalId\":19500,\"journal\":{\"name\":\"Open Access Journal of Clinical Trials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2012-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/OAJCT.S33292\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Access Journal of Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/OAJCT.S33292\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OAJCT.S33292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 8

摘要

Jacqueline Le Goaster1 Sylvie Gonzalo2 Patrice boure1 Frederic tang3 Anne-Lise Haenni4 1巴黎第十一大学医院中心(CHU)热带病科，Le Kremlin Bicetre, 2塞纳河畔艾夫里生物医学实验室，3巴黎巴斯德研究所国家科学研究中心(CNRS)逆转录病毒学;4巴黎第七大学国家科学研究中心雅克·莫诺研究所，巴黎

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Efficacy of the anti-VZV (anti-HSV3) vaccine in HSV1 and HSV2 recurrent herpes simplex disease: a prospective study

Jacqueline Le Goaster1 Sylvie Gonzalo2 Patrice Bouree1 Frederic Tangy3 Anne-Lise Haenni4 1Department of Tropical Diseases, Centre Hospitalo-Universitaire (CHU), University of Paris XI, Le Kremlin Bicetre, 2Biomnis Laboratory, Ivry-sur-Seine, 3Retro-Virology, Centre National de Recherche Scientifique (CNRS), Pasteur Institute, Paris; 4Jacques Monod Institute, Centre National de Recherche Scientifique (CNRS), University of Paris VII, Paris, France

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Open Access Journal of Clinical Trials MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

3.90

自引率

0.00%

发文量

审稿时长

16 weeks